Experienced private equity and operations executive focused on growth-stage healthcare and tech investments, Joyce Provost combines investor and operator perspectives to source and scale portfolio companies. She has led deal execution, value-creation programs and board oversight across commercial growth, M&A and performance improvement. Background spans operational leadership in clinical services and strategic investing; typically works with middle-market buyouts and growth equity with a focus on revenue growth and margin expansion.
Experienced private equity and operations executive focused on growth-stage healthcare and tech investments, Joyce Provost combines investor and operator perspectives to source and scale portfolio companies. She has led deal execution, value-creation programs and board oversight across commercial growth, M&A and performance improvement. Background spans operational leadership in clinical services and strategic investing; typically works with middle-market buyouts and growth equity with a focus on revenue growth and margin expansion.
Combines operator-driven private equity discipline with growth-stage focus, prioritizing healthcare and tech businesses where revenue acceleration and margin expansion are achievable through commercial transformation and operational improvement. Emphasizes rigorous due diligence, active board-level engagement, and hands-on value-creation plans—commercial go-to-market, M&A integration, and performance improvement—favoring middle-market buyouts and growth equity with a multi-year horizon and targeted, risk-adjusted returns.
Combines operator-driven private equity discipline with growth-stage focus, prioritizing healthcare and tech businesses where revenue acceleration and margin expansion are achievable through commercial transformation and operational improvement. Emphasizes rigorous due diligence, active board-level engagement, and hands-on value-creation plans—commercial go-to-market, M&A integration, and performance improvement—favoring middle-market buyouts and growth equity with a multi-year horizon and targeted, risk-adjusted returns.
| Trades 1386 | Longs Won 939/1386 67% | Profit Factor 8.53 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $546,366.63 |
| Average Win $122,407.6 | Best Trade (Oct 14) $11.61M | Sharpe Ratio -85.83 |
| Average Loss -$30,153.73 | Worst Trade (Sep 29) -$605,554.31 | Z-Score 9.64 (100%) |
| Commissions $0 | Avg. Trade Length 1y 4m 1w 4d | Expectancy $73,161.93 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 8,696 | 7,826 | 6,957 | 6,087 | 5,217 | 4,348 | 3,478 | 2,609 | 1,739 | 870 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 72,259 | $14.03M | $24.88M | - | $10.85M | 77.36% | +0.684% |
ABBV AbbVie Inc. | 20,394 | $3.64M | $5.8M | - | $2.16M | 59.3% | +0.349% |
ADCT ADC Therapeutics S.A. | 10,343 | $46,439.75 | $14,842.2 | - | -$31,597.55 | -68.04% | -3.367% |
AMAT Applied Materials, Inc. | 2,672 | $573,785.19 | $1.13M | - | $554,493.53 | 96.64% | -1.802% |
AMD Advanced Micro Devices, Inc. | 3,483 | $558,808.56 | $1.89M | - | $1.33M | 237.75% | -3.62% |
AMGN Amgen Inc. | 2,681 | $811,272.27 | $1.17M | - | $359,091.47 | 44.26% | +0.578% |
AMZN Amazon.com Inc | 34,467 | $5.58M | $8.75M | - | $3.17M | 56.9% | -0.326% |
APO Apollo Global Management, Inc. | 2,276 | $215,954.97 | $259,520.9 | - | $43,565.93 | 20.17% | +1.926% |
AVGO Broadcom Inc. | 11,760 | $1.42M | $3.98M | - | $2.57M | 181.43% | -1.655% |
AXP American Express Company | 736 | $206,394.55 | $234,327.68 | - | $27,933.13 | 13.53% | +1.437% |
BA Boeing Company | 13,319 | $3.03M | $2.56M | - | -$478,917.22 | -15.78% | +1.648% |
BAC Bank of America Corporation | 56,612 | $2.48M | $2.95M | - | $473,555.78 | 19.11% | +0.861% |
BKNG Booking Holdings Inc. | 2,775 | $453,224.65 | $464,340.75 | - | $11,116.1 | 2.45% | +0.923% |
| BPRE BPRE | 21,374 | $323,244.44 | $320,610 | - | -$2,634.44 | -0.81% | 0.0 |
BRK-B Berkshire Hathaway Inc. | 5,635 | $2.14M | $3M | - | $852,712.02 | 39.76% | +1.195% |
BX Blackstone Inc. | 5,569 | $729,308.05 | $613,648.11 | - | -$115,659.94 | -15.86% | +0.907% |
BXSL Blackstone Secured Lending Fund | 42,628 | $1.25M | $1.03M | - | -$214,427.98 | -17.22% | -0.041% |
C Citigroup Inc. | 7,390 | $483,203.57 | $930,327.1 | - | $447,123.53 | 92.53% | +2.175% |
CAT Caterpillar Inc. | 1,164 | $450,850.48 | $860,487 | - | $409,636.52 | 90.86% | +0.491% |
CEG Constellation Energy Corporation | 3,813 | $716,924.91 | $1.04M | - | $327,837.09 | 45.73% | -0.364% |